Sei Investments Co. Reduces Stake in Maximus, Inc. (MMS)

Sei Investments Co. reduced its stake in shares of Maximus, Inc. (NYSE:MMS) by 81.6% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 4,534 shares of the health services provider’s stock after selling 20,155 shares during the period. Sei Investments Co.’s holdings in Maximus were worth $283,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Acrospire Investment Management LLC increased its position in shares of Maximus by 183.3% in the first quarter. Acrospire Investment Management LLC now owns 1,700 shares of the health services provider’s stock valued at $106,000 after buying an additional 1,100 shares during the period. Glen Harbor Capital Management LLC increased its position in shares of Maximus by 1.9% in the first quarter. Glen Harbor Capital Management LLC now owns 2,332 shares of the health services provider’s stock valued at $145,000 after buying an additional 44 shares during the period. Elkfork Partners LLC acquired a new position in shares of Maximus during the fourth quarter valued at approximately $162,000. Meadow Creek Investment Management LLC increased its position in shares of Maximus by 1.9% in the first quarter. Meadow Creek Investment Management LLC now owns 3,604 shares of the health services provider’s stock valued at $224,000 after buying an additional 68 shares during the period. Finally, World Asset Management Inc increased its position in shares of Maximus by 0.8% in the first quarter. World Asset Management Inc now owns 3,976 shares of the health services provider’s stock valued at $247,000 after buying an additional 30 shares during the period. 98.34% of the stock is currently owned by institutional investors.

Institutional Ownership by Quarter for Maximus (NYSE:MMS)

Shares of Maximus, Inc. (NYSE:MMS) opened at 63.15 on Monday. The company’s 50-day moving average price is $62.93 and its 200-day moving average price is $59.50. Maximus, Inc. has a 12 month low of $43.69 and a 12 month high of $64.97. The company has a market cap of $4.09 billion, a P/E ratio of 20.70 and a beta of 1.45.

Maximus (NYSE:MMS) last released its earnings results on Thursday, May 4th. The health services provider reported $0.80 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.78 by $0.02. Maximus had a return on equity of 26.21% and a net margin of 8.18%. The firm had revenue of $622 million during the quarter, compared to analysts’ expectations of $620.24 million. During the same period in the previous year, the firm posted $0.74 EPS. Maximus’s revenue for the quarter was up 2.6% on a year-over-year basis. Equities analysts forecast that Maximus, Inc. will post $3.05 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, May 31st. Investors of record on Monday, May 15th were paid a dividend of $0.045 per share. The ex-dividend date was Thursday, May 11th. This represents a $0.18 annualized dividend and a yield of 0.29%. Maximus’s payout ratio is 5.86%.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by Mideast Time and is owned by of Mideast Time. If you are accessing this report on another site, it was stolen and republished in violation of United States & international copyright & trademark law. The original version of this report can be viewed at https://www.mideasttime.com/sei-investments-co-reduces-stake-in-maximus-inc-mms/1810310.html.

MMS has been the topic of several research analyst reports. Canaccord Genuity reaffirmed a “buy” rating and issued a $62.00 price objective on shares of Maximus in a research report on Friday, April 7th. ValuEngine downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Tuesday, May 16th. Jefferies Group LLC downgraded Maximus from a “buy” rating to a “hold” rating and increased their price target for the stock from $63.00 to $64.00 in a research report on Friday, May 5th. Maxim Group downgraded Maximus from a “buy” rating to a “hold” rating and set a $66.00 price target on the stock. in a research report on Thursday, May 4th. They noted that the move was a valuation call. Finally, KeyCorp reissued a “sector weight” rating on shares of Maximus in a research report on Thursday, May 25th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and one has issued a buy rating to the company’s stock. The company currently has an average rating of “Hold” and an average target price of $61.33.

In related news, insider Mark Andrekovich sold 8,939 shares of the business’s stock in a transaction on Friday, June 9th. The stock was sold at an average price of $64.01, for a total transaction of $572,185.39. Following the completion of the transaction, the insider now directly owns 24,583 shares of the company’s stock, valued at approximately $1,573,557.83. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, General Counsel David Francis sold 1,500 shares of the business’s stock in a transaction on Thursday, April 20th. The stock was sold at an average price of $59.91, for a total value of $89,865.00. Following the transaction, the general counsel now directly owns 19,716 shares of the company’s stock, valued at $1,181,185.56. The disclosure for this sale can be found here. Insiders have sold a total of 121,846 shares of company stock valued at $7,645,191 over the last three months. 3.10% of the stock is currently owned by insiders.

Maximus Company Profile

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS).

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.



Leave a Reply

 
© 2006-2017 Mideast Time.